Home » Health » Pfizer will soon have more data on children under 5 receiving a Covid-19 vaccine

Pfizer will soon have more data on children under 5 receiving a Covid-19 vaccine

(Photo de Yui Mok/PA Images via Getty Images)

  • Pfizer CEO Albert Bourla said on Friday there would be more data on children under five receiving a Covid-19 vaccine by the end of the year.
  • Pfizer has started pediatric vaccine trials. Moderna and Johnson & Johnson also plan to conduct trials.
  • Pfizer’s announcement comes as the new Omicron variant begins to roll out in the United States.
  • For more stories go to www.BusinessInsider.co.za.

Pfizer CEO Albert Bourla said on Friday the company expects to learn more about the effectiveness of its vaccines in children under 5 by the end of the year.

“We have a study in children six months to two years old, then another cohort of children aged 2 to 5,” said Bourla, speaking in an interview with NBC News. ” So [by] end of year, beginning of next year, when we see the data, we will know more. ”

Anyone five years of age and older can get the coronavirus vaccine in the United States. Children under 5 are the only group of people in the United States who cannot yet get the Covid-19 vaccine.

Dr Anthony Fauci, the country’s leading Covid-19 expert, has predicted that parents won’t have to wait much longer for children under 5 to receive one.

“Hopefully within a reasonably short period of time, possibly early next year in 2022, in the first quarter of 2022, it will be available to them,” Fauci said, according to a report from Hilary Brueck from the insider. Fauci, however, said there was no way to know for sure without additional data.

“I can’t guarantee it, you have to do the clinical trial,” he said.

Pfizer’s Friday announcement on data for children under 5 comes as the Omicron variant of the coronavirus has been detected in the United States. So far, scientists from at least 10 states said they detected the variant. The could be around 2,000 cases of the variant in the United States already, according to a calculation made by a former senior official in the California Department of Public Health.

South Africa, where scientists were the first to sound the alarm bells about Omicron, has seen an increase in hospital admissions among children under 4 amid a fourth wave of Covid-19 infections. A health officer panic not recommended, noting that the infections have so far been mild.

Pfizer has started pediatric vaccine trials. Moderna and Johnson & Johnson also plan to conduct trials on the effectiveness of the vaccine in young children.

In a joint interview with Bourla, Moderna CEO Stéphane Bancel did not say when data from the vaccine manufacturer would be available.

“With kids you want to get down very slowly in age,” Bancel said. “And start at a low dose, then slowly increase the dose level to find the right one. So it takes a little longer because the safety of these children in these studies is very important to all of us. “

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.